Oral drug delivery is an essential part of drug delivery and pharmaceutical industry. People with a condition called dysphagia (difficulty in swallowing) require oral administration of drugs. Thus, oral thin film medication are developed for swift oral administration of drugs.
To improve patient compliance various types of vaccines and hormones are developed by the market players.
Technological advancement in drug discovery and development processes, less bio-availability of solid drugs, and inaccurate dosage by liquid formulations is expected to boost the market growth for oral dissolvable films market.
However, challenges related to drug development and massive research investment required for creation of simple and novel formulation is expected to hinder the market.

The global Oral Dissolvable Films market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Oral Dissolvable Films volume and value at global level, regional level and company level. From a global perspective, this report represents overall Oral Dissolvable Films market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Oral Dissolvable Films in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Oral Dissolvable Films manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
MonoSol
Tesa Labtec
IntelGenX
BioDelivery Sciences
Cynapsus Therapeutics
FFT Medical
Innoteq
Acadia Pharmaceuticals
Neuroderm
Transition Therapeutics

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Oral Dispersible
Sublingual
Buccal

Segment by Application
Pharma & Healthcare
Others